- Report
- February 2024
- 70 Pages
Europe
From €4233EUR$4,750USD£3,672GBP
- Report
- April 2023
- 111 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- April 2023
- 110 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- October 2022
- 113 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- May 2024
- 200 Pages
Global
From €3698EUR$4,150USD£3,208GBP
- Report
- May 2024
- 200 Pages
Global
From €3698EUR$4,150USD£3,208GBP
- Report
- May 2024
- 200 Pages
Global
From €3698EUR$4,150USD£3,208GBP
- Report
- May 2024
- 200 Pages
Global
From €3698EUR$4,150USD£3,208GBP
- Report
- May 2024
- 200 Pages
Global
From €3698EUR$4,150USD£3,208GBP
- Report
- March 2024
- 200 Pages
Global
From €3698EUR$4,150USD£3,208GBP
- Report
- August 2023
- 145 Pages
Global
From €2807EUR$3,150USD£2,435GBP
- Report
- May 2024
- 140 Pages
Global
From €4410EUR$4,949USD£3,826GBP
- Report
- February 2024
- 180 Pages
Global
From €4428EUR$4,969USD£3,841GBP
- Report
- September 2023
- 160 Pages
Global
From €3207EUR$3,599USD£2,782GBP
- Report
- April 2023
- 147 Pages
Global
From €4410EUR$4,949USD£3,826GBP
- Report
- April 2023
- 147 Pages
Global
From €4410EUR$4,949USD£3,826GBP
- Report
- April 2023
- 150 Pages
Global
From €2896EUR$3,250USD£2,512GBP
€4322EUR$4,850USD£3,749GBP
- Report
- December 2023
- 150 Pages
Global
From €3965EUR$4,450USD£3,440GBP
- Report
- November 2023
- 185 Pages
Global
From €3965EUR$4,450USD£3,440GBP
- Report
- May 2022
- 240 Pages
Global
From €3965EUR$4,450USD£3,440GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more